Castleark Management’s Qiagen QGEN Stock Holding History

Castleark Management’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-72,776	Closed	-$3.14M	–	386
2019 Q1	$3.14M	Sell	72,776 -1,480	-2%	-$59.5K	0.12%	188
2018 Q4	$2.71M	Sell	74,256 -73,606	-50%	-$2.73M	0.12%	197
2018 Q3	$5.94M	Sell	147,862 -12,462	-8%	-$498K	0.17%	179
2018 Q2	$6.15M	Buy	+160,324	New	+$5.9M	0.19%	171

Other funds holding QGEN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Castleark Management's QGEN Position: Q2 2019 in Review

Castleark Management sold out of Qiagen (QGEN) in Q2 2019, closing a stake of 72,776 shares — an estimated $3.14M sold.

Castleark Management first reported a position in QGEN in Q2 2018 and held it in 4 quarters. The position peaked at $6.15M in Q2 2018. 262 funds tracked by Wall St. Rank hold QGEN as of Q2 2019.

Castleark Management reported no remaining Qiagen position as of Q2 2019 after selling out during the quarter.
Castleark Management sold 72,776 Qiagen shares in Q2 2019, an estimated $3.14M.
Castleark Management first reported a position in Qiagen in Q2 2018 and held it in 4 quarters.
Castleark Management's Qiagen position peaked at $6.15M in Q2 2018.
262 funds tracked by Wall St. Rank held Qiagen as of Q2 2019.

Based on Castleark Management's 13F filing for Q2 2019, filed 13 Aug 2019.